Emergence of Ceftriaxone Resistant Shigella.
Summary of "Emergence of Ceftriaxone Resistant Shigella."
Shigellosis is endemic in many resource-poor countries due to feco-oral transmission, resulting in considerable morbidity and mortality. There is rapid emergence of multi-drug resistant (MDR) Shigella spp. resulting in poor reliability of first line antibiotics like quinolones, co-trimoxazole and ampicillin. Ceftriaxone has been used as a reserved antibiotic for treatment of MDR Shigella spp. The authors report a case of ceftriaxone resistant Shigella flexneri successfully managed with meropenem. As occurrence of ceftriaxone resistant Shigella is still rare, the objective of reporting this case is to highlight the possible failure of ceftriaxone in treating shigellosis which if not detected timely can result in mortality.
Affiliation
Department of Clinical Microbiology and Immunology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, 110060, India.
Journal Details
This article was published in the following journal.
Name: Indian journal of pediatrics
ISSN: 0973-7693
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22205379
- DOI: http://dx.doi.org/10.1007/s12098-011-0669-5
Medical and Biotech [MESH] Definitions
Dysentery, Bacillary
DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).
Shigella Boydii
One of the SHIGELLA species that produces bacillary dysentery (DYSENTERY, BACILLARY).
Shigella Vaccines
Vaccines or candidate vaccines used to prevent bacillary dysentery (DYSENTERY, BACILLARY) caused by species of SHIGELLA.
Ceftriaxone
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
Tuberculosis, Multidrug-resistant
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.
PubMed Articles
Ceftriaxone resistant Shigella Flexneri, an emerging problem.
Shigellosis is a disease of public health importance in developing countries. It may cause self-limited diarrhea to severe dysentery. Emergence of multi drug resistant (MDR) strains is a growing conce...
On October 20, 2010, the South Carolina Department of Health and Environmental Control and CDC began investigating a cluster of three diarrheal illnesses caused by multidrug-resistant Shigella flexner...
Plasmid-mediated streptomycin and sulfamethoxazole resistance in Shigella flexneri 3a.
Shigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in children in developing countries such as India. Recently, it was estimated that 91 million individuals worldwid...
Research progress in Shigella in the postgenomic era.
Gram-negative, facultative intracellular anaerobes of the genus Shigella, the principal etiologic agents of shigellosis, continue to pose a threat to public health. Shigellosis causes 1.1 million deat...
Emergence and Spread of Drug Resistant Neisseria gonorrhoeae.
PURPOSE: The emergence and spread of Neisseria gonorrhoeae with resistance to oral antibiotics have led to difficulty in treating gonorrhea. We review drug resistance in N. gonorrhoeae with a particul...
Clinical Trials
Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children
Acute lower respiratory tract infections are a leading cause of morbidity and mortality in sub Saharan Africa. The World Health Organisation (WHO) still recommends intravenous chlorampheni...
The purpose of this study is to determine whether CVD 1208S (a live, attenuated, oral vaccine) is safe and effective in the prevention of Shigella infection.
Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora
Bacterial resistance to antibiotics has been a growing therapeutic problem since the late 1980s. Resistant strains of pathogenic bacteria can arise through initial selection of resistant s...
The objectives of this study are: - to establish the safety of subcutaneous administration of ceftriaxone at different concentrations, with and without HYLENEX recombinant, and to...
Therapeutic Induction of Endogenous Antibiotics
Shigellosis is one of the major causes of morbidity and mortality in many developing countries. The continued emergence of antibiotic resistant strains has complicated the treatment of shi...
